(ran PC edition)
The two are accused of selling a substance as an Alzheimer's treatment without prescriptions.
A man who sought to have a potentially toxic drug approved as an over-the-counter treatment for Alzheimer's disease has been charged with selling it through the mail and over the Internet.
The eight-count indictment against James T. Kimball, 60, unsealed Tuesday charged him with conspiracy to violate the Food, Drug and Cosmetic Act.
Kimball, who prosecutors said manufactured deprenyl, allegedly conspired to distribute the drug throughout the United States between 1995 and 1999 and attempted to send a 108-bottle shipment to England.
Kimball, of Wesley Chapel, also was charged with six counts of unlawful distribution of deprenyl to people without prescriptions, and with making a false statement to the U.S. Customs Service.
Gaylord Hughes, who also goes by the name Hugo Lord, was charged with the same counts.
Kimball was released on bond after his first court appearance Tuesday.
Hughes, of Phoenix, surrendered to the U.S. Marshal's Office there.
Kimball applied twice to the Food and Drug Administration to have liquid deprenyl citrate approved as a non-prescription drug for Alzheimer's, the U.S. Attorneys Office said in a statement.
Both applications, made through his company Discovery Experimental & Development Inc., were rejected in 1992.
The active ingredient in the liquid drug can be toxic when used with other drugs, including some antidepressants, and with certain foods and drinks, prosecutors allege.
The conspiracy charge carries a maximum sentence of five years in prison and a $250,000 fine. Each count of distributing the drug carries a maximum sentence of three years in prison and $250,000 in fines.